Shots:

• Abbott’s Gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) are developed for heart rhythm disorders including patient-preferred design without compromising battery longevity and MRI compatibility also allows Bluetooth connectivity on the smartphones for improved remote monitoring- increased patient/physician engagement and streamlined communications
• The Gallant pairs with Abbott's secure myMerlinPulse for streamline communication between doctors and their patients suitable for both iOS and Android. Additionally- it allows to access data device performance- transmission history and helps in continues monitoring for asymptomatic episodes leading to early intervention
• Abbott’s Gallant has also received the CE Mark which offers treatment plans and the increased facilities for the patient leading to better outcomes

Click here to read full press release/ article 

Ref: Abbott | Image: Abbott